A novel RP – HPLC methodology for method development and validation of aceclofenac and tizanidine pharmaceutical dosage forms
Keywords:Liquid Chromatography, UV Spectroscopy, Validation, Aceclofenac, Tizanidine
A simple and selective LC technique is chosen for the determination of Aceclofenac and Tizanidine in pill indefinite quantity forms. Chromatographic process separation was achieved on a c18 column victimization mobile part consisting of a combination of fifty volumes of Triethylamine buffer, fifty volumes of acetonitrile with detection of 230nm. Dimensionality was discovered within the vary 5-15 µg/ml for aceclofenac (r2 =0.999) and 1-3 µg /ml for tizanidine (r2 =0.998) for the number of medicine calculable by the planned strategies was in smart agreement with the label claim. The planned strategies have a sound procedure. At three completely different levels the accuracy of the strategies was assessed by recovery studies. The recovery experiments indicated the absence of interference from unremarkably encountered pharmaceutical additives showing %RSD below a pair of this technique was found to be precise as indicated by the repeatability analysis. All applied mathematics information proves all ways have valid procedure and might be used for routine analysis of pharmaceutical dose kind
Hamilton RJ. Tarascon Pocket Pharmacopoeia. Jones & Bartlett Learning, London, (2014).
Sanjay KD, Kumar HD. Importance of RP-HPLC in analytical method development: A review. Int. J. Pharm. Sci. Res., 3, 4626–33 (2012).
Legrand E. Aceclofenac in the management of inflammatory pain. Expert Opin Pharmacother 5, 1347-57. (2004)..
Moore RA, Derry S, McQuay HJ. Single dose oral aceclofenac for postoperative pain in adults. Cochrane Database Syst Rev, 8, CD007588. (2009)
Raza K, Kumar M, Kumar P, Malik R, Sharma G, Kaur M, Katare OP. Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems. Biomed Res Int 2014, 406731. (2014).
Pareek A, Chandurkar N. Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis. Curr Med Res Opin 29, 849-59. (2013).
Pareek A, Chandurkar N, Gupta A, Sirsikar A, Dalal B, Jesalpura B, Mehrotra A, Mukherjee A. Efficacy and safety of aceclofenac-cr and aceclofenac in the treatment of knee osteoarthritis: a 6-week, comparative, randomized, multicentric, double-blind study. J Pain 12, 546-53. (2011).
National Center for Biotechnology Information (2020). PubChem Compound Summary for CID 5487, Tizanidine. Retrieved October 18, 2020 from https://pubchem.ncbi.nlm.nih.gov/compound/Tizanidine.
Tizanidine, Drug Bank, https://www.drugbank.ca/drugs/DB00697
Ghanavatian S, Derian A. Tizanidine. [Updated 2020 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519505/
Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357, 1933-6. (2001).
Siva Kumar R, Kumar Nallasivan P, Vijai Anand PR, Akelesh T, Venkatnarayanan R. Spectrophotometric methods for simultaneous estimation of aceclofenac and tizanidine. Int. J. PharmTech Res., 2, 945–9 (2010).
Vaidya V V, Singh GR, Choukekar MP, Kekare MB. Simultaneous RP HPLC determination of aceclofenac, paracetamol and tizanidine in pharmaceutical preparations. E-Journal Chem., 7, 260–4 (2010).
Patil PP, Ware AL, Hon PA. Development and validation of RP-HPLC method for simultaneous determination of diclofenac sodium and tizanidine hydrochloride in bulk and tablet formulation. J. Anal. Pharm. Res., 7, (2018).
Sinha S, Rajput MS. Validated simultaneous multicomponent spectrophotometric determination of paracetamol, aceclofenac and tizanidine in tablets. Int. J. ChemTech Res., 3, 963–6 (2011).
Siva Kumar R, Nathan Senthil P, Nallasivan KP, Sam Solomon WD, Venkatnarayanan R. A validated reversed phase HPLC-method for the determination of aceclofenac and tizanidine in tablets. Asian J. Pharm. Res. Heal. Care, 2, 84–94 (2010).
How to Cite
Copyright (c) 2020 Adilakshmi Nenavath, Nellore Dharani Sai Sreekanth
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.